At Next Genomix Laboratories, we provide a variety of diagnostic testing to assist clinicians in making informed decisions about therapy or monitoring a patient's progress. We examine 49 different genes and over 120 variants to generate an easy-to-understand report on 15 medication classes and 182 pharmacological medicines.
What Are The Most Common Diagnostic Tests?
What Are The Most Common Diagnostic Tests?

Pharmacogenetic Testing
This is a genetic test that examines how a person's genes affect their response to medications. It can help identify which medications are likely to work best for a particular person and which medications may cause adverse effects. Pharmacogenomics is becoming an increasingly important tool for clinicians.

Punch Biopsy Testing
A punch biopsy is a procedure in which a small sample of tissue is taken from the skin for examination under a microscope. It is used to diagnose skin conditions, such as psoriasis, acne, and eczema.

COVID-19 Testing
In this day and age, knowing if you have COVID when you're feeling under the weather is a necessity for keeping friends, family, and loved ones safe. Next Genomix Laboratories offers COVID-19 testing for individuals, and we use PCR technology to detect the virus in respiratory specimens. If the test is done before 1 p.m., our staff provides PCR COVID-19 testing that offers same-day results. After 1 p.m., any appointment will have results the next day. We can also do large group tests for organizations, corporations, and clinics using our services.

What to Expect From Next Genomix Laboratories
Next Genomix Laboratories is a full-service diagnostic laboratory that offers a variety of testing services to assist clinicians in making informed decisions about therapy or monitoring a patient's progress. We use the latest technology and offer a wide range of tests to suit your needs.

We want to make sure you have the best possible experience when you visit us, so please call us today to schedule an appointment and rest assured that you're in good hands with Next Genomix.